Cargando…
Doxycycline inhibits experimental cerebral malaria by reducing inflammatory immune reactions and tissue-degrading mediators
Malaria ranks among the most important infectious diseases worldwide and affects mostly people living in tropical countries. Mechanisms involved in disease progression are still not fully understood and specific treatments that might interfere with cerebral malaria (CM) are limited. Here we show tha...
Autores principales: | Schmidt, Kim E., Kuepper, Janina M., Schumak, Beatrix, Alferink, Judith, Hofmann, Andrea, Howland, Shanshan W., Rénia, Laurent, Limmer, Andreas, Specht, Sabine, Hoerauf, Achim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5811026/ https://www.ncbi.nlm.nih.gov/pubmed/29438386 http://dx.doi.org/10.1371/journal.pone.0192717 |
Ejemplares similares
-
Specific Depletion of Ly6C(hi) Inflammatory Monocytes Prevents Immunopathology in Experimental Cerebral Malaria
por: Schumak, Beatrix, et al.
Publicado: (2015) -
Newly acquired Onchocerca volvulus filariae after doxycycline treatment
por: Specht, Sabine, et al.
Publicado: (2009) -
Protection of Batf3‐deficient mice from experimental cerebral malaria correlates with impaired cytotoxic T‐cell responses and immune regulation
por: Kuehlwein, Janina M., et al.
Publicado: (2019) -
Therapeutic Efficacy and Macrofilaricidal Activity of Doxycycline for the Treatment of River Blindness
por: Walker, Martin, et al.
Publicado: (2015) -
Cerebral malaria: Mysteries at the blood-brain barrier
por: Rénia, Laurent, et al.
Publicado: (2012)